| 中文名称 | 依诺他滨 |
| 英文名称 | Enocitabine |
| CAS号 | 55726-47-1 |
| 分子式 | C31H55N3O6 |
| 分子量 | 565.78 |
| EINECS号 | 1312995-182-4 |
| 熔点 | 141-142°C |
| 比旋光度 | D +70° (c = 1 in THF, 22°) |
| 沸点 | 630.87°C (rough estimate) |
| 密度 | 1.0967 (rough estimate) |
| 折射率 | 1.7800 (estimate) |
| 溶解度 | DMSO(微溶,加热),甲醇(微溶,加热),THF(微溶,加热,Soncited) |
| 形态 | 固体 |
| 酸度系数(pKa) | 10.14±0.20(Predicted) |
| 颜色 | 白色至类白色 |
DNA replication; CMV
Enocitabine is resistant to deamination because Enocitabine bears a highly lipophilic group at the 4-amino position of the cytosine moiety of cytarabine.
The combined effects of Pirarubicin and Enocitabine on HeLa S3 human uterine cervix carcinoma and K562 human myelocytic leukemia cells are determined by enhancement of their cytotoxic activities. Enocitabine or etoposide shows synergistic effects on HeLa S3 and K562 cells.
In the presence of Enocitabine, triphosphate forms of the nucleoside analogs are detected in the human cytomegalovirus (HCMV)-infected cells, and synthesis of HCMV DNA is strongly suppressed.